Investment and M&A transaction comps
Supplement Brand Investment & M&A Transaction Comps
Supplements, vitamins, sports nutrition, wellness and functional nutrition brand transactions.
68
Reviewed transactions
43
With price data
3.6x
Median EV or valuation / revenue
17.4x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 15 | 9 | 3.7x | - |
| 2024 | 3 | 3 | 5.5x | 15.0x |
| 2023 | 6 | 4 | 3.3x | 21.2x |
| 2022 | 6 | 2 | 1.8x | 22.0x |
| 2021 | 5 | 3 | 3.1x | 11.4x |
| 2020 | 8 | 6 | 5.0x | 15.7x |
| 2018 | 5 | 4 | 5.6x | 17.6x |
| 2017 | 6 | 4 | 3.6x | 19.0x |
Sortable transaction comps
Supplements transaction table
Rows with reported value
17 / 25
Acquisition EV, USD
USD 33B
Investment EV, USD
USD 1.3B
Median EV / revenue
3.6x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 68 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AuNutra Industries Control | 2026-10-19 | Vivify Specialty Ingredients | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Specnova Control | 2026-10-09 | HTBA | Undisclosed | Undisclosed | - | - | United States | Confirmed 2 sources | ||
| Medici Brands Capital Raise | 2026-09-02 | Greenoaks; Valor Equity Partners; Peter Rahal; Iconiq; Imaginary Ventures | USD 250M Investment Amount | 250 | - | - | United States | Confirmed 2 sources | ||
| Twinlab Control | 2026-09-02 | cbdMD | Undisclosed Consideration | Undisclosed | - | - | - | Confirmed 4 sources | ||
| Nestlé Holistic Health Platform Control | 2026-09-01 | Yellow Wood Partners | USD 1.0B Consideration | 1,000 | - | - | - | Confirmed 2 sources | ||
| Jamieson Wellness Control (100%) | 2026-08-06 | Kirin Holdings Company | CAD 2.5B Enterprise Value | 1,785 | - | - | Canada | Confirmed 1 source | ||
| Thorne Control | 2026-08-04 | Procter & Gamble | USD 3.8B Consideration | 3,800 | 7.6x | - | United States | Estimated 3 sources | ||
| BIO-CAT Enzymes & Microbials Control | 2026-07-31 | Lallemand Inc. | Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Vitabiotics Control | 2026-07-24 | Bain Capital | USD 1.0B Estimated Enterprise Value | 1,038 | - | - | United Kingdom | Confirmed 3 sources | ||
| IM8 Capital Raise | 2026-07-14 | General Catalyst Customer Value Fund | USD 1.0B Investment Amount | 1,000 | - | - | - | Estimated 2 sources | ||
| Imaraïs Beauty Control | 2026-05-18 | Healthy Extracts | USD 20.0M Consideration | 20 | - | - | - | Confirmed 1 source | ||
| SuppCo Control | 2026-05-13 | Function | Undisclosed | Undisclosed | - | - | - | Confirmed 1 source | ||
| Tally Health Control | 2026-04-29 | Infinite Epigenetics | Undisclosed | Undisclosed | - | - | - | Confirmed 2 sources | ||
| Grüns Control (80%) | 2026-04-09 | Unilever | EUR 959M Enterprise Value | 1,120 | 3.7x | - | United States | Estimated 7 sources | ||
| Huel Control (100%) | 2026-03-23 | Danone | EUR 1.0B Enterprise Value | 1,160 | 3.5x | 34.8x | United Kingdom | Estimated 3 sources | ||
| Zywie Ventures Private Limited (OZiva) Control (49%) | 2026-02-12 | Hindustan Unilever Limited (HUL) | INR 17B Enterprise Value | 186 | 3.5x | - | India | Confirmed 6 sources | ||
| Nutraceutical Wellness, Inc. (Nutrafol) Minority (20%) | 2025-04-01 | Unilever | Undisclosed Investment Amount | Undisclosed | - | - | - | Confirmed 5 sources | ||
| GHOST Lifestyle LLC Control (60%) | 2024-12-31 | Keurig Dr Pepper Inc. | USD 1.7B Enterprise Value | 1,665 | - | - | - | Estimated 54 sources | ||
| Opella Control (50%) | 2024-10-21 | Clayton, Dubilier & Rice | EUR 16B Enterprise Value | 17,365 | 3.1x | 14.0x | France, United States & Global | Confirmed 1 source | ||
| Sunday Natural Control (55%) | 2024-01-15 | CVC Capital Partners | EUR 800M Enterprise Value | 875 | 8.0x | 16.0x | Germany | Estimated 1 source | ||
| Lactobio Control | 2023-12-04 | L’Oréal | Undisclosed Undisclosed | Undisclosed | - | - | Denmark | Confirmed 1 source | ||
| Bonafide Health Control | 2023-11-30 | Pharmavite | USD 425M Consideration | 425 | - | - | - | Confirmed 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| Adare Biome Control (100%) | 2023-04-19 | dsm-firmenich AG | EUR 275M Enterprise Value | 301 | - | 18.0x | France & Global | Confirmed 1 source |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.